Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
63.46 USD | -0.35% | +1.34% | -17.61% |
Apr. 23 | Bio-Techne Says It Filed Patent Infringement Lawsuit Against Molecular Instruments in Europe | MT |
Apr. 18 | Deutsche Bank Adjusts Bio-Techne Price Target to $82 From $85 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.61% | 10.01B | |
+5.02% | 43.43B | |
+48.09% | 41.69B | |
+10.31% | 41.31B | |
-10.82% | 27.14B | |
+10.06% | 25.28B | |
-24.30% | 18.47B | |
+35.58% | 12.59B | |
+2.32% | 12.33B | |
+8.52% | 11.03B |
- Stock Market
- Equities
- TECH Stock
- News Bio-Techne Corporation
- Bio Techne : JV ScaleReady Starts Wednesday Seeking to Make T Cell Therapy Manufacturing Practical, Viable